ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
RCPI was delisted on the 4th of November, 2015.
77 hedge funds and large institutions have $13.8M invested in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 77 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
950% more call options, than puts
Call options by funds: $2.39M | Put options by funds: $228K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Goldman Capital Management
New York
|
+$3.89M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.84M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.08M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.13M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$667K |
Top Sellers
RCPI Hedge Fund Activity: Q2 2014 in Review
77 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) for Q2 2014, worth a combined $13.8M.
Buyers outnumbered sellers: 77 funds opened new RCPI positions and 0 closed out — a net gain of 77 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Goldman Capital Management, opening a new position worth an estimated $3.89M.
- 77 institutional investors held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) as of Q2 2014, up from 0 in Q1 2014.
- Funds reported $13.8M of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) stock for Q2 2014.
- 77 funds opened new ROCK CREEK PHARMACEUTICALS INC COM STK (DE) positions in Q2 2014 and 0 closed out, a net change of +77 holders.
- The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) buyer in Q2 2014 was Goldman Capital Management, an estimated $3.89M added.
Based on aggregated 13F filings for Q2 2014.